Major Depressive Disorder In Chronic Kidney Disease
A regional Virtual Live Event for PsychU members in KS and OK, and NephU members in NM, OK, TX, and AR.There is a high prevalence of depression among patients with […]
User experience form
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
Learn about the clinical, laboratory and histological risk predictors that make up the International IgAN Prediction Tool and gain an understanding of its clinical utility and future potential.Read More
Registered Dietitian Lauren Levy and Kidney-Friendly Chef Anthony Valentine come together to bring their expertise in nutrition and IgAN, including discussing the basics of nutritional concepts – such as sodium and protein – in patients with IgAN.Read More
Learn about the clinical, laboratory and histological risk predictors that make up the International IgAN Prediction Tool and gain an understanding of its clinical utility and future potential.Read More
A regional Virtual Live Event for PsychU members in KS and OK, and NephU members in NM, OK, TX, and AR.There is a high prevalence of depression among patients with […]
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an […]
Join us as we discuss the challenges patients with end-stage kidney disease face and explore the barriers and benefits of living kidney donation. Our speaker, Glenna Frey, APRN-CNS, is an […]
Join us as we discuss the challenges patients with end-stage kidney disease face and explore the barriers and benefits of living kidney donation. Our speaker, Glenna Frey, APRN-CNS, is an […]
As part of our Patient Empowerment series, this presentation brings you concepts and resources to help improve health literacy among your patients, especially those with chronic kidney disease, as they […]
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an […]
Join PKD experts from across the country, where you can hear the most current information on PKD pathophysiology, disease progression, and the physical and emotional burden of PKD. Objectives Review […]
Did you know that Black patients with autosomal dominant polycystic kidney disease (ADPKD) progress to end-stage kidney disease (ESKD) earlier than White patients?1,2 Please join us for a virtual panel […]
Did you know that Black patients with autosomal dominant polycystic kidney disease (ADPKD) progress to end-stage kidney disease (ESKD) earlier than White patients?1,2 Please join us for a virtual panel […]
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an […]
This presentation, Autosomal Dominant Polycystic Kidney Disease (ADPKD): Disease Progression, will discuss various risk-assessment tools to help identify patients at risk for rapid progression of the disease. This is a […]
Patient empowerment is an important concept in the care of patients with chronic kidney disease. This presentation discusses the foundational aspects of motivational interviewing, basic counseling techniques, and the importance […]